Institut de Recherches Cliniques de Montréal (IRCM)
Montreal, Quebec, H2W 1R7, Canada
NCT Number: NCT01297946
Recent developments of continuous glucose sensors and insulin infusion pumps have motivated the research toward closed-loop strategies to regulate glucose levels in patients with type 1 diabetes. In a closed-loop strategy, the pump(s) infusion rate is altered based on a computer-generated recommendation that relies on continuous glucose sensor readings. In this study, we aim to compare the effectiveness of dual-hormone (insulin+glucagon) closed-loop strategy to open-loop conventional continuous subcutaneous insulin infusion pump (CSII) therapy in regulating glucose levels during an evening exercise and on a night following an exercise in adults with type 1 diabetes.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 1 / Phase 2
Montreal, Quebec, H2W 1R7, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 p.m. - 7 a.m.
Time frame: 4 p.m. - 7 a.m.
Time frame: 4 p.m. - 7 a.m
Time frame: 11 p.m. - 7 a.m.
Time frame: 11 p.m. - 7 a.m.
Time frame: 11 p.m. - 7 a.m.
Time frame: 4 p.m. - 7 a.m.
Time frame: 11 p.m. - 7 a.m.
Time frame: 4 p.m. - 7 a.m.
Time frame: 4 p.m. - 7 a.m.
Time frame: 11 p.m. - 7 a.m
Time frame: 5:50 p.m. - 7:20 p.m
Time frame: 4 p.m. - 7 a.m.
Time frame: 11 p.m. - 7 a.m
Time frame: 5:50 p.m. - 7:20 p.m
Time frame: 4 p.m. - 7 a.m.
Time frame: 11 p.m. - 7 a.m
Time frame: 5:50 p.m. - 7:20 p.m
Institut de Recherches Cliniques de Montreal
Other
An Open-label, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Dual-hormone Closed-loop Strategy as Compared to Conventional CSII Therapy in Regulating Glucose Levels in Adults With Type-1 Diabetes in the Context of Exercise
Acronym: CLASS-01
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05488119
Autoimmune Diseases, Diabetes Mellitus
Stanford, California, United States
View Trial DetailsNCT07696780
Autoimmune Diseases, Diabetes Mellitus
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT05610111
Autoimmune Diseases, Diabetes Mellitus
Charlottesville, Virginia, United States
View Trial DetailsNCT06308549
Autoimmune Diseases, Diabetes Distress
Bad Mergentheim, Baden-Wurttemberg, Germany
View Trial Details